RETRACTED: Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure (Retracted Article)

被引:4
|
作者
Li, Zhiyong [1 ]
Rong, Hui [2 ]
Wu, Wenxun [3 ]
Huang, Ting [4 ]
Xu, Jun [1 ]
机构
[1] Gen Hosp Pingxiang Min Grp Co Ltd Liabil, Dept Geriatr, Pingxiang 337035, Jiangxi, Peoples R China
[2] Gen Hosp Pingxiang Min Grp Co Ltd Liabil, Dept Internal Med Cardiovasc, Pingxiang 337035, Jiangxi, Peoples R China
[3] Gen Hosp Pingxiang Min Grp Co Ltd Liabil, Clin Lab, Pingxiang 337035, Jiangxi, Peoples R China
[4] Gen Hosp Pingxiang Min Grp Co Ltd Liabil, Dept Hematol, Pingxiang 337035, Jiangxi, Peoples R China
关键词
TO-LYMPHOCYTE RATIO; CARDIOVASCULAR EVENTS; NEUTROPHIL; DIAGNOSIS;
D O I
10.1155/2022/3689445
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To explore the application value of N-terminal pro-B type natriuretic peptide (NT-proBNP) combined with neutrophil-to-lymphocyte ratio (NLR) in evaluation of major adverse cardiac events (MACEs) in elderly patients with chronic heart failure (CHF). Methods. 50 CHF patients admitted to the Department of Cardiovascular Medicine of our hospital from January 2021 to December 2021 were selected as the observation group. Another 50 non-CHF patients of our hospital were selected as the control group. Clinical data were collected from subjects who met the inclusion criteria, including general information, personal disease history, and laboratory test indicators. Patients with CHF were followed up for 6 months. Patients with CHF were divided into two groups, MACE group and non-MACE group. Results. The levels of WBC, NEU, NLR, and NT-proBNP in observation group were higher than those in control group, but the level of LYM was the opposite (P < 0.05). The age, WBC, NEU, LYM, PLT, blood glucose, NLR, and NT-proBNP of MACE group and non-MACE group were significantly different (P < 0.05). The increased levels of NEU, NLR, NT-proBNP and the decreased levels of LYM and PLT are all independent risk factors for MACE in elderly patients with CHF (P < 0.05). The AUC of NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.841. When the Youden index was 0.7692, the sensitivity was 76.92% and the specificity was 100.00%. The AUC of NT-proBNP in evaluating the occurrence of MACE in elderly CHF patients was 0.705. When the Youden index was 0.5260, the sensitivity was 76.92% and the specificity was 75.68%. The AUC of NT-proBNP combined with NLR in evaluating the occurrence of MACE in elderly CHF patients was 0.954. When the Youden index was 0.8420, the sensitivity was 92.31% and the specificity was 91.89%. Conclusion. NT-proBNP combined with NLR has high value in the evaluation of MACE in elderly CHF patients and can be used as an auxiliary predictive index in clinic.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Prognostic value of NT-proBNP and best cut-offs for risk prediction in obese patients with chronic systolic heart failure
    Gentile, F.
    Aimo, A.
    Januzzi, J. L. J.
    Richards, A. M.
    Lam, C. S. P.
    Latini, R.
    Anand, I. S.
    Ueland, T.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Huber, K.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1002 - 1002
  • [42] Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
    Zhang, Jing
    Liu, Wen-Xian
    Lyu, Shu-Zheng
    CARDIOVASCULAR THERAPEUTICS, 2020, 2020
  • [43] RETRACTED: The Importance of Pleural Fluid and Serum NT-proBNP Levels in Differentiating Pleural Effusion due to Heart Failure from Other Causes of Effusion (Retracted article. See vol. 48, pg. 1783, 2009)
    Seyhan, Ekrem Cengiz
    Altin, Sedat
    Cetinkaya, Erdogan
    Sokucu, Sinem
    Gunluoglu, Mehmet Zeki
    Demir, Adalet
    Korkmaz, Pelin
    Issever, Halim
    INTERNAL MEDICINE, 2009, 48 (05) : 287 - 293
  • [44] RETRACTED ARTICLE: Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI
    Lijun Gan
    Dandan Sun
    Yuntao Cheng
    Deyang Wang
    Fen Wang
    Lin Wang
    Wei Li
    Dandan Shen
    Daotong Guo
    Zonglei Zhang
    Haiyan Wang
    Jinli Li
    Yong Yang
    Tao Liang
    BMC Cardiovascular Disorders, 21
  • [45] Velocity Vector Imaging and NT-ProBNP to Quantify Systolic Function and Intraventricular Mechanical Dyssynchrony to Predict Cardiac Outcome in Patients with Chronic Heart Failure
    Faida, O.
    Oteh, M.
    Lattif, A. M.
    Fadillah, A. W.
    INTERNATIONAL JOURNAL OF COLLABORATIVE RESEARCH ON INTERNAL MEDICINE & PUBLIC HEALTH, 2012, 4 (12) : 2044 - 2064
  • [46] Suboptimal accuracy of the ED physician and NT-proBNP levels to diagnose heart failure in elderly patients with dyspnoea: the Akershus Cardiac Examination (ACE) 2 Study
    Brynildsen, J.
    Hoiseth, A. D.
    Nygard, S.
    Hagve, T. A.
    Christensen, G.
    Omland, T.
    Rosjo, H.
    EUROPEAN HEART JOURNAL, 2013, 34 : 132 - 132
  • [47] Predictive Value of the Lipoprotein(a) to Prealbumin Ratio and of the NT-proBNP to LVEF Ratio for Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
    Zhang, Yingqian
    Shi, Fangyuan
    HEART SURGERY FORUM, 2023, 26 (05): : E470 - E477
  • [48] RETRACTED: Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine (Retracted Article)
    Lu, Yingyi
    Wang, Fenglian
    Ni, Haoxuan
    Sun, Ying
    Shi, Hailing
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [49] Treatment With Omecamtiv Mecarbil, a Cardiac Myosin Activator, Improves NT-proBNP in Patients With Chronic Heart Failure: A Responder Analysis From COSMIC-HF
    Teerlink, John R.
    Felker, G. Michael
    Solomon, Scott D.
    Niegowska, Joanna
    Szachniewicz, Joanna
    Tomcsanyi, Janos
    Barr, Craig S.
    Johnston, James T.
    Buchele, Gustavo L.
    Malik, Fady I.
    CIRCULATION, 2017, 136
  • [50] Prognostic utility of combination of NT-proBNP and cardiac troponin T in patients hospitalized for worsening chronic heart failure with preserved left ventricular systolic function
    Kitagawa, F.
    Ishii, J.
    Kuno, A.
    Nakashima, A.
    Naruse, H.
    Matsui, S.
    Ishikawa, T.
    Tanaka, I.
    Hishida, H.
    Ozaki, Y.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A79 - A79